KRT14 and cancer: Moreover, this “class 2” subtype highly expressed KRT14 and genetic signatures related to late cell cycle, cancer stem cell phenotype and EMT, which was in accord with another report that found high CK14/KRT14 to be a determinant of poor NMIBC prognosis (19).